GLP-1 Drugs May Protect Against Cancer, Here’s What That Means For Public Health

Article excerpt

Research increasingly suggests that GLP-1 drugs, the class of medications that includes Ozempic and Wegovy, may offer protection against certain cancers, potentially reshaping public health strategy around weight loss and disease prevention. The mechanism appears tied to how these drugs regulate blood sugar and reduce inflammation, factors linked to cancer development. If the protective effect holds up in larger studies, it could transform how doctors prescribe these medications beyond their current use for diabetes and obesity. The implications are significant: millions of Americans already use GLP-1s, and expanded evidence of cancer prevention could drive even wider adoption and insurance coverage. However, experts caution that more research is needed before making sweeping public health recommendations.